Navigation Links
Blood test developed for malignant hyperthermia

Experts have developed a blood test to determine the genetical predisposition for a rare condition// called malignant hyperthermia.

Malignant hyperthermia is an inherited disorder that can affect the patient during or after general anesthesia. This condition may be triggered by volatile anesthetics or depolarizing muscle relaxants that have to work together with a genetical predisposition to cause the condition. The symptoms often include tachycardia, arrhythmia and rising body temperature where muscles of the skeletal system get affected.

Previously it was impossible for physicians to know if the patients can be susceptible to the condition of malignant hyperthermia. So instead of prevention, importance were placed on treatment. With the new test, things are expected to change for both the anesthetist and the patient.

The new blood test, developed by researchers from The Children's Hospital of Philadelphia, US, is effective in detecting 25 to 50 % of the mutations known that can make the patient susceptible to the condition. The effectiveness of the test is expected to increase with use. Once the anesthesiologist finds out that the patient may be susceptible to this condition, it will become possible to substitute the drugs for those that will not trigger the condition.

Reference: Journal of the American Medical Association, June 2005
'"/>




Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Blood test developed for malignant hyperthermia

(Date:8/4/2015)... Ohio (PRWEB) , ... August 04, 2015 , ... ... have up-to-date immunizations, especially those entering kindergarten. All required immunizations are covered for ... rules, which means that children who aren’t caught up with their immunizations may ...
(Date:8/4/2015)... ... August 04, 2015 , ... NutraScience Labs , ... fulfillment services, joined over 200 other Long Island-based corporations as participants in the ... 28th at Jones Beach State Park in Wantagh, New York. , According to ...
(Date:8/4/2015)... ... August 04, 2015 , ... Mesothelioma researchers in Australia have ... may be a viable option. Surviving Mesothelioma has just posted an article on ... surgeons at the University of New South Wales, peritoneal mesothelioma patients ...
(Date:8/4/2015)... ... 2015 , ... Providigm, LLC, a developer of quality management ... of the Advanced level of their national accreditation for Quality Assurance and Performance ... , introduced in 2013, is based on standards for excellence in continuously improving ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... Channel Report, finds the North America IT reseller channel will grow at least ... rates ahead of their 2014 pace and greater than their OEM/vendor partners. ...
Breaking Medicine News(10 mins):Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3
... -- People with Parkinson,s disease appear to be at ... greater risk may extend to their close and distant ... School of Medicine researchers discovered the possible connection after ... contains birth, death and family relationship data for more ...
... that the United States begin to live within its means and ... nation we need to be smart about how we do it. ... it means for America,s future jeopardizes the very future we want ... century, science and technology have been the primary drivers of job ...
... -- Nearly one-fifth of U.S. college students who took part ... of them mistakenly believe that hookah smoking is safer than ... sample of students at eight North Carolina colleges and universities ... a hookah, nearly as many students (46.6 percent) who said ...
... 8 (HealthDay News) -- All exercise is the same, right? ... of Scotland that found that high-intensity exercise may be better ... be done in less time. The study included 57 ... assigned to high-intensity or moderate-intensity exercise groups. Both groups ...
... By Dennis Thompson HealthDay Reporter , FRIDAY, April ... problems were those of a typical teenage girl. The 16-year-old ... grumpy. Teenage stuff. Except she also felt sick, like she ... morning before she went to school. And she had shingles. ...
... Mozes HealthDay Reporter , THURSDAY, April 7 (HealthDay ... in her struggle to maintain a healthy weight. "The ... things worse, as after finishing the diet I put the ... driver from the Wurzburg region of Germany. "So, I researched ...
Cached Medicine News:Health News:Parkinson's May Have Links to Certain Cancers, Study Suggests 2Health News:US House budget plans would jeopardize scientific research facilities 2Health News:Hookah Use Common Among College Students, Survey Finds 2Health News:Short Bursts of Exercise Good for the Heart: Study 2Health News:Coping With Graves' Disease Lasts a Lifetime 2Health News:Coping With Graves' Disease Lasts a Lifetime 3Health News:Could Stomach 'Pacemaker' Be New Weight-Loss Tool? 2Health News:Could Stomach 'Pacemaker' Be New Weight-Loss Tool? 3Health News:Could Stomach 'Pacemaker' Be New Weight-Loss Tool? 4
(Date:8/3/2015)... , Aug. 4, 2015   The Intellectual ... the world,s leading provider of intelligent information for ... 2015 CMR Pharmaceutical R&D Factbook , the ... Despite concerns around declines in R&D, the analysis ... $1 trillion milestone and forecasts sales to reach ...
(Date:8/3/2015)... (NASDAQ: LMNX ) today announced financial results for ... operating highlights for the quarter include the following: ... percent to $58.9 million, over the second quarter of ... by 22 percent to $24.2 million over results from ... 2015 royalty revenue by 17 percent to $11.1 million ...
(Date:8/3/2015)... -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), a ... of innovative therapies for the treatment of acute pain, ... for the three and six months ended June 30, ... July 23, 2015, the Committee for Medicinal Products for ... for the management of acute moderate-to-severe post-operative pain in ...
Breaking Medicine Technology:Pharma Sales to Grow Beyond $1 Trillion 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10
... and Progressive Form of Inflammatory Spinal Arthritis Receiving Monthly Golimumab ... ... BOSTON, Nov. 7 More than half of patients receiving,monthly ... experienced significant and sustained improvements in the signs and,symptoms of active ...
... of Trial Volunteers Must Remain Paramount Concern, SEATTLE, ... the following statement today from Executive,Director Mitchell Warren in ... AIDS vaccine study by Merck & Co., the US ... HIV Vaccine Trials Network,(HVTN) at a public forum at ...
Cached Medicine Technology:New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 2New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 3New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 4New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 5New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 6New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 7AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 2AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 3
... Dual Power is a microprocessor-controlled programmable ... high voltage/low current and high current/low ... current section is ideal for sample ... sequencing applications. The low voltage/high current ...
... These modified battery ... power supplies for GENIE ... to produce very specific ... reproducibility than laboratory power ...
Inquire...
... Power Supply . The digital 200 V/2000 ... 2 A in 1 volt and 10 mA ... to three SEA 2000® apparatus simultaneously at 55°C. ... actual values of voltage, current and time • ...
Medicine Products: